v3.26.1
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2026
SHAREHOLDERS' EQUITY  
Schedule of Equity-Classified Warrants

The following table presents a summary of the activity for the Company’s equity-classified warrants during the three and six months ended June 30, 2026:

 

 

 

Number of Warrants

 

Weighted Average Exercise Price

 

Weighted Average Remaining Contractual Life (Years)

Total outstanding, December 31, 2025

 

1,896,928

 

$

23.29

 

  2.57

Granted

 

-

 

 

-

 

-

Exercised

 

-

 

 

-

 

-

Forfeited

 

-

 

 

-

 

-

Expired

 

-

 

 

-

 

-

Total outstanding, March 31, 2026

 

1,896,928

 

$

23.29

 

2.32

Granted

 

-

 

 

-

 

-

Exercised

 

-

 

 

-

 

-

Forfeited

 

-

 

 

-

 

-

Expired

 

-

 

 

-

 

-

Total outstanding, June 30, 2026

 

1,896,928

 

$

23.29

 

2.07

Total exercisable, June 30, 2026

 

1,896,928

 

$

23.29

 

2.07

 

The following table presents a summary of the activity for the Company’s equity-classified warrants during the three and six months ended June 30, 2025:

 

 

 

Number of Warrants

 

Weighted Average Exercise Price

 

Weighted Average Remaining Contractual Life (Years)

Total outstanding, December 31, 2024(1)

 

441,277

 

$

70.37

 

3.26

Granted

 

186,807

 

 

14.24

 

2.00

Exercised

 

(96,300)

 

 

0.02

 

 Indefinite

Forfeited

 

-

 

 

-

 

-

Expired

 

-

 

 

-

 

-

Total outstanding, March 31, 2025

 

531,784

 

$

63.39

 

    2.60

Granted

 

-

 

 

-

 

-

Exercised

 

-

 

 

-

 

-

Forfeited

 

-

 

 

-

 

-

Expired

 

-

 

 

-

 

-

Total outstanding, June 30, 2025

 

531,784

 

$

63.39

 

2.60

Total exercisable, June 30, 2025

 

531,784

 

$

63.39

 

2.60

 

(1)

Weighted average remaining contractual life at December 31, 2024 excludes 96,300 Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date, for which 0 warrants remain outstanding and exercisable at March 31, 2025 and June 30, 2025.